Drug Information

General Information
Drug ID
DR01371
Drug Name
9-Aminocamptothecin
Synonyms
IDEC-132; (S)-10-Amino-4-ethyl-4-hydroxy-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14-dione; 9-Amino-20(S)-camptothecin
Drug Type
Small molecular drug
Indication Ovarian cancer [ICD11: 2C73] Phase 2 [1]
Structure
3D MOL 2D MOL
Formula
C20H17N3O4
Canonical SMILES
CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC=C5N=C4C3=C2)N)O
InChI
InChI=1S/C20H17N3O4/c1-2-20(26)13-7-16-17-10(6-11-14(21)4-3-5-15(11)22-17)8-23(16)18(24)12(13)9-27-19(20)25/h3-7,26H,2,8-9,21H2,1H3/t20-/m0/s1
InChIKey
FUXVKZWTXQUGMW-FQEVSTJZSA-N
CAS Number
CAS 91421-43-1
Pharmaceutical Properties Molecular Weight 363.4 Topological Polar Surface Area 106
Heavy Atom Count 27 Rotatable Bond Count 1
Hydrogen Bond Donor Count 2 Hydrogen Bond Acceptor Count 6
XLogP
0.3
PubChem CID
72402
PubChem SID
483848 , 600881 , 8195177 , 11408968 , 12014702 , 14876953 , 14876954 , 26725257 , 43128571 , 50028358 , 57318699 , 77695393 , 87560557 , 96023346 , 99373552 , 99432308 , 103073229 , 103082936 , 103170467 , 103910998 , 103922005 , 104352855 , 117586313 , 119525751 , 124796287 , 124953919 , 127347071 , 127903358 , 135030378 , 137138142 , 142371086 , 152036014 , 152227690 , 160809182 , 162179182 , 162937855 , 163374696 , 164758081 , 170559265 , 172860100 , 174531450 , 178115205 , 179151428 , 184538696 , 188900245 , 198973567 , 223445740 , 223603491 , 225031198 , 226414396
ChEBI ID
CHEBI:80755
TTD Drug ID
D07UHX
DT(s) Transporting This Drug BCRP Transporter Info Breast cancer resistance protein Substrate [2]
References
1 ClinicalTrials.gov (NCT00001427) A Phase II Trial of 72-Hour Continuous IV Infusion of 9-Aminocamptothecin With G-CSF Support in Patients With Advanced Ovarian Cancer Previously Treated With Paclitaxel and Cisplatin
2 Pharmacogenomic importance of ABCG2. Pharmacogenomics. 2008 Aug;9(8):1005-9.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.